» Articles » PMID: 35741675

Vitamin D Status and Parkinson's Disease

Overview
Journal Brain Sci
Publisher MDPI
Date 2022 Jun 24
PMID 35741675
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is a complex and progressive neurodegenerative disease, characterized by resting tremor, rigidity, slowness of movement, and postural instability. Furthermore, PD is associated with a wide spectrum of non-motor symptoms that add to overall disability. In recent years, some investigations, from basic science to clinical applications, have focused on the role of vitamin D in PD, often with controversial findings. Vitamin D has widespread effects on several biological processes in the central nervous system, including neurotransmission in dopaminergic neural circuits. Various studies have recorded lower levels of vitamin D in PD patients than in healthy controls. Low vitamin D status has also been correlated with the risk for PD and motor severity, whereas less is known about the effects vitamin D has on cognitive function and other non-motor symptoms. This review aims to better characterize the correlation between vitamin D and PD, clarify the role of vitamin D in PD prevention and treatment, and discuss avenues for future research in this field.

Citing Articles

Association of 25-hydroxyvitamin D with Parkinson's disease based on the results from the NHANES 2007 to 2018 and Mendelian randomization analysis.

Xu Y, Peng J, Zhou X, Huang Y, Zhong G, Xia Z Sci Rep. 2025; 15(1):5514.

PMID: 39953081 PMC: 11828982. DOI: 10.1038/s41598-025-87120-6.


Microbiome-based therapies for Parkinson's disease.

Alam M, Abbas K, Mustafa M, Usmani N, Habib S Front Nutr. 2024; 11:1496616.

PMID: 39568727 PMC: 11576319. DOI: 10.3389/fnut.2024.1496616.


Food and Food Waste Antioxidants: Could They Be a Potent Defence against Parkinson's Disease?.

Cannas C, Lostia G, Serra P, Peana A, Migheli R Antioxidants (Basel). 2024; 13(6).

PMID: 38929084 PMC: 11200518. DOI: 10.3390/antiox13060645.


Parkinson's disease and vitamins: a focus on vitamin B12.

Rekik A, Santoro C, Poplawska-Domaszewicz K, Qamar M, Batzu L, Landolfo S J Neural Transm (Vienna). 2024; 131(12):1495-1509.

PMID: 38602571 PMC: 11608379. DOI: 10.1007/s00702-024-02769-z.


Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson's Disease Patients with and without Dyskinesia: A Preliminary Examination.

Milanowski J, Nuszkiewicz J, Lisewska B, Lisewski P, Szewczyk-Golec K Metabolites. 2024; 14(2).

PMID: 38392998 PMC: 10890066. DOI: 10.3390/metabo14020106.


References
1.
Barichella M, Cereda E, Iorio L, Pinelli G, Ferri V, Cassani E . Clinical correlates of serum 25-hydroxyvitamin D in Parkinson's disease. Nutr Neurosci. 2020; 25(6):1128-1136. DOI: 10.1080/1028415X.2020.1840117. View

2.
Arici Duz O, Yilmaz N . Nocturnal blood pressure changes in Parkinson's disease: correlation with autonomic dysfunction and vitamin D levels. Acta Neurol Belg. 2019; 120(4):915-920. DOI: 10.1007/s13760-019-01113-7. View

3.
Feldman D, Krishnan A, Swami S, Giovannucci E, Feldman B . The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014; 14(5):342-57. DOI: 10.1038/nrc3691. View

4.
. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989; 129(4):687-702. View

5.
Lv L, Zhang H, Tan X, Qin L, Peng X, Bai R . Assessing the Effects of Vitamin D on Neural Network Function in Patients With Parkinson's Disease by Measuring the Fraction Amplitude of Low-Frequency Fluctuation. Front Aging Neurosci. 2022; 13:763947. PMC: 8721225. DOI: 10.3389/fnagi.2021.763947. View